BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34068442)

  • 1. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
    Kishi S; Nishiguchi Y; Honoki K; Mori S; Fujiwara-Tani R; Sasaki T; Fujii K; Kawahara I; Goto K; Nakashima C; Kido A; Tanaka Y; Luo Y; Kuniyasu H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
    Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
    Pang X; Zhang Y; Zhang S
    Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus.
    Zhou Y; Liu SX; Zhou YN; Wang J; Ji R
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1339-1350. PubMed ID: 33629304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases.
    Nass N; Ignatov A; Andreas L; Weißenborn C; Kalinski T; Sel S
    Histochem Cell Biol; 2017 May; 147(5):625-634. PubMed ID: 28012130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1.
    Li Y; Qin C
    Hum Cell; 2019 Jul; 32(3):352-359. PubMed ID: 30903594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 facilitates migration of neural stem cells via receptor for advanced glycation end products signaling pathway.
    Xue X; Chen X; Fan W; Wang G; Zhang L; Chen Z; Liu P; Liu M; Zhao J
    Sci Rep; 2018 Mar; 8(1):4513. PubMed ID: 29540727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J; Kou YB; Zhu JS; Chen WX; Li S
    Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of CML-Modified as Well as Heat-Glycated β-lactoglobulin to Receptors for AGEs Is Determined by Charge and Hydrophobicity.
    Zenker HE; Teodorowicz M; Ewaz A; van Neerven RJJ; Savelkoul HFJ; De Jong NW; Wichers HJ; Hettinga KA
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
    Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
    Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer.
    Yue Y; Zhou T; Gao Y; Zhang Z; Li L; Liu L; Shi W; Su L; Cheng B
    Tumour Biol; 2017 Mar; 39(3):1010428317694312. PubMed ID: 28347236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
    Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions.
    Watanabe M; Toyomura T; Tomiyama M; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
    Mol Biol Rep; 2020 Sep; 47(9):7153-7159. PubMed ID: 32885364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.
    Paek J; Lee M; Nam EJ; Kim SW; Kim YT
    Arch Gynecol Obstet; 2016 Mar; 293(3):645-50. PubMed ID: 26305032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury.
    Yang J; Zhang F; Shi H; Gao Y; Dong Z; Ma L; Sun X; Li X; Chang S; Wang Z; Qu Y; Li H; Hu K; Sun A; Ge J
    FASEB J; 2019 Dec; 33(12):14410-14422. PubMed ID: 31665609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyoxal-derived advanced glycation end-products, N
    Kang J; Jeong YJ; Ha SK; Lee HH; Lee KW
    Mol Biol Rep; 2023 Mar; 50(3):2511-2520. PubMed ID: 36609749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1.
    Goto K; Fujiwara-Tani R; Nukaga S; Miyagawa Y; Kawahara I; Nishida R; Ikemoto A; Sasaki R; Ogata R; Kishi S; Luo Y; Fujii K; Ohmori H; Kuniyasu H
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.